Vaccinia virus-encoded ribonucleotide reductase: sequence conservation of the gene for the small subunit and its amplification in hydroxyurea-resistant mutants.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMC 250563)

Published in J Virol on February 01, 1988

Authors

M Slabaugh1, N Roseman, R Davis, C Mathews

Author Affiliations

1: Department of Biochemistry and Biophysics, Oregon State University, Corvallis 97331-6503.

Articles citing this

Poxvirus pathogenesis. Microbiol Rev (1991) 3.54

Sequence and transcriptional analysis of the vaccinia virus HindIII I fragment. J Virol (1988) 1.49

Transcriptional mapping and nucleotide sequence of a vaccinia virus gene encoding a polypeptide with extensive homology to DNA ligases. Nucleic Acids Res (1989) 1.43

Intramolecular homologous recombination in cells infected with temperature-sensitive mutants of vaccinia virus. J Virol (1989) 1.33

M protein (M1) of influenza virus: antigenic analysis and intracellular localization with monoclonal antibodies. J Virol (1989) 1.24

Retroviral protease-like gene in the vaccinia virus genome. Proc Natl Acad Sci U S A (1989) 1.24

Identification of multiple independent horizontal gene transfers into poxviruses using a comparative genomics approach. BMC Evol Biol (2008) 1.18

Glutaredoxin homolog encoded by vaccinia virus is a virion-associated enzyme with thioltransferase and dehydroascorbate reductase activities. Proc Natl Acad Sci U S A (1992) 1.11

Cloning, sequence determination, and regulation of the ribonucleotide reductase subunits from Plasmodium falciparum: a target for antimalarial therapy. Proc Natl Acad Sci U S A (1993) 1.10

Molecular genetic analysis of vaccinia virus DNA polymerase mutants. J Virol (1989) 1.07

Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis. PLoS Pathog (2010) 1.03

Amplification of the ribonucleotide reductase small subunit gene: analysis of novel joints and the mechanism of gene duplication in vaccinia virus. Nucleic Acids Res (1989) 1.00

Deoxyadenosine reverses hydroxyurea inhibition of vaccinia virus growth. J Virol (1991) 0.99

Vaccinia virus encodes a polypeptide with DNA ligase activity. Nucleic Acids Res (1989) 0.98

In vitro resolution of poxvirus replicative intermediates into linear minichromosomes with hairpin termini by a virally induced Holliday junction endonuclease. J Virol (1992) 0.98

Vaccinia virus encodes a thymidylate kinase gene: sequence and transcriptional mapping. Nucleic Acids Res (1989) 0.97

Adaptive gene amplification as an intermediate step in the expansion of virus host range. PLoS Pathog (2014) 0.95

Vaccinia virus vectors: new strategies for producing recombinant vaccines. Clin Microbiol Rev (1990) 0.92

Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir. Antimicrob Agents Chemother (1989) 0.92

A mechanism for induction of a hypoxic response by vaccinia virus. Proc Natl Acad Sci U S A (2013) 0.84

Experimental Evolution Identifies Vaccinia Virus Mutations in A24R and A35R That Antagonize the Protein Kinase R Pathway and Accompany Collapse of an Extragenic Gene Amplification. J Virol (2015) 0.78

A role for vaccinia virus protein C16 in reprogramming cellular energy metabolism. J Gen Virol (2014) 0.78

Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer models. EMBO Mol Med (2017) 0.75

Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses. Front Oncol (2017) 0.75

Articles cited by this

DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01

A general method applicable to the search for similarities in the amino acid sequence of two proteins. J Mol Biol (1970) 155.96

RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry (1977) 38.82

DNA sequence analysis with a modified bacteriophage T7 DNA polymerase. Proc Natl Acad Sci U S A (1987) 37.15

Construction of phylogenetic trees. Science (1967) 23.69

Gene amplification. Annu Rev Biochem (1984) 5.83

Gene amplification in cultured animal cells. Cell (1984) 5.43

Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment. J Virol (1986) 3.88

Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus. Virology (1983) 3.33

Retroviruses and retrotransposons: the role of reverse transcription in shaping the eukaryotic genome. Cell (1985) 2.97

Identification and isolation of the gene encoding the small subunit of ribonucleotide reductase from Saccharomyces cerevisiae: DNA damage-inducible gene required for mitotic viability. Mol Cell Biol (1987) 2.97

Homology between RNA polymerases of poxviruses, prokaryotes, and eukaryotes: nucleotide sequence and transcriptional analysis of vaccinia virus genes encoding 147-kDa and 22-kDa subunits. Proc Natl Acad Sci U S A (1986) 2.71

Primary structure of the Escherichia coli ribonucleoside diphosphate reductase operon. Proc Natl Acad Sci U S A (1984) 2.54

Creation of a processed pseudogene by retroviral infection. Cell (1987) 2.30

The preparation of orthopoxvirus DNA. J Virol Methods (1981) 2.28

Vaccinia virus produces late mRNAs by discontinuous synthesis. Cell (1987) 2.26

Nucleotide sequence and genetic map of the 16-kb vaccinia virus HindIII D fragment. Virology (1986) 2.25

Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis. J Biol Chem (1984) 2.19

The mechanism of cytoplasmic orthopoxvirus DNA replication. Cell (1981) 2.16

Restriction enzyme mapping of vaccinia virus DNA. J Virol (1982) 2.15

Isolation and characterization of expressible cDNA clones encoding the M1 and M2 subunits of mouse ribonucleotide reductase. Mol Cell Biol (1986) 1.81

The small subunit of ribonucleotide reductase is encoded by one of the most abundant translationally regulated maternal RNAs in clam and sea urchin eggs. J Cell Biol (1985) 1.68

The bacteriophage T4 gene for the small subunit of ribonucleotide reductase contains an intron. EMBO J (1986) 1.64

Homology between two EBV early genes and HSV ribonucleotide reductase and 38K genes. Nucleic Acids Res (1984) 1.57

Identification of the stable free radical tyrosine residue in ribonucleotide reductase. EMBO J (1986) 1.47

High-frequency homologous recombination in vaccinia virus DNA. J Virol (1987) 1.39

Vaccinia virus induces ribonucleotide reductase in primate cells. J Virol (1984) 1.33

A 3' co-terminus of two early herpes simplex virus type 1 mRNAs. Nucleic Acids Res (1982) 1.33

Ribonucleotide reductase induced by herpes simplex type 1 virus. Characterization of a distinct enzyme. J Biol Chem (1983) 1.31

Structural features of ribonucleotide reductase. Proteins (1986) 1.30

Vaccinia virus infection of synchronized pig kidney cells. J Virol (1967) 1.18

Identification of the stable free radical tyrosine residue in ribonucleotide reductase. A sequence comparison. FEBS Lett (1985) 1.18

Ribonucleoside diphosphate reductase induced by bacteriophage T4. II. Allosteric regulation of substrate sepecificity and catalytic activity. J Biol Chem (1972) 1.14

Nucleotide sequence and transcript organization of a region of the vaccinia virus genome which encodes a constitutively expressed gene required for DNA replication. J Virol (1987) 1.14

Transcriptional and translational analysis of the vaccinia virus late gene L65. J Virol (1985) 1.13

Identification and nucleotide sequence of the thymidine kinase gene of Shope fibroma virus. J Virol (1986) 1.09

Insertion and deletion mutants of vaccinia virus. Virology (1986) 1.02

Hydroxyurea-resistant vaccinia virus: overproduction of ribonucleotide reductase. J Virol (1986) 0.98

Altered expression of ribonucleotide reductase and role of M2 gene amplification in hydroxyurea-resistant hamster, mouse, rat, and human cell lines. Somat Cell Mol Genet (1987) 0.89

Vaccinia virus-induced ribonucleotide reductase can be distinguished from host cell activity. J Virol (1984) 0.86

Differential accumulation of ribonucleotide reductase subunits in clam oocytes: the large subunit is stored as a polypeptide, the small subunit as untranslated mRNA. J Cell Biol (1986) 0.86

Gene amplification mechanism for the hyperproduction of T4 bacteriophage gene 17 and 18 proteins. J Mol Biol (1987) 0.84

Pattern matching of biological sequences with limited storage. Comput Appl Biosci (1987) 0.79

Articles by these authors

(truncated to the top 100)

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature (1997) 10.14

The myoD gene family: nodal point during specification of the muscle cell lineage. Science (1991) 9.53

The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem (2000) 7.41

JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev (1994) 4.50

Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet (2001) 4.12

Y-Chromosome evidence for a northward migration of modern humans into Eastern Asia during the last Ice Age. Am J Hum Genet (1999) 3.60

Muscle-specific transcriptional activation by MyoD. Genes Dev (1991) 3.37

BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults. Rheumatology (Oxford) (2006) 3.22

MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation. Proc Natl Acad Sci U S A (1990) 3.14

Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem (2000) 2.92

Multicentre randomised control trial comparing real time teledermatology with conventional outpatient dermatological care: societal cost-benefit analysis. BMJ (2000) 2.77

Gender gap in cystic fibrosis mortality. Am J Epidemiol (1997) 2.74

The process of infection with Bacteriophage phi-X174. XXIX. In vivo studies on the synthesis of the single-stranded DNA of progeny phi-X174 bacteriophage. J Mol Biol (1969) 2.59

Physicians attitudes toward homosexuality. West J Med (1984) 2.52

c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol Cell Biol (1994) 2.41

A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant (2012) 2.25

Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am J Physiol Endocrinol Metab (2001) 2.24

The discovery of potent cRaf1 kinase inhibitors. Bioorg Med Chem Lett (2000) 2.22

Designing studies of computer-based alerts and reminders. MD Comput (1995) 2.15

Pediatric evidence-based medicine: past, present, and future. J Pediatr (2000) 2.06

Establishment of two human prostate cancer cell lines derived from a single bone metastasis. Clin Cancer Res (1997) 2.02

Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling. J Biol Chem (1997) 2.00

Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J (2001) 1.93

GermOnline, a cross-species community knowledgebase on germ cell differentiation. Nucleic Acids Res (2004) 1.90

A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med (1991) 1.89

Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood (2000) 1.87

6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity. J Med Chem (2001) 1.83

Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics. Pharmacoepidemiol Drug Saf (2002) 1.79

The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem (2000) 1.77

Prevalence of postnatal psychiatric morbidity in mothers and fathers. Br J Psychiatry (1994) 1.73

Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme. N Engl J Med (1979) 1.73

Autologous blood collection service. Med J Aust (1994) 1.70

Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc Natl Acad Sci U S A (1998) 1.70

Electron microscopic localization of acetylcholinesterase and nonspecific cholinesterase at the neuromuscular junction by the gold-thiocholine and gold-thiolacetic acid methods. J Cell Biol (1967) 1.69

Transcatheter closure of atrial septal defects. Experimental studies. Circulation (1989) 1.68

Comparison of teleconsultations and face-to-face consultations: preliminary results of a United Kingdom multicentre teledermatology study. Br J Dermatol (1998) 1.63

Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol (1997) 1.63

Computer-based consultations in clinical therapeutics: explanation and rule acquisition capabilities of the MYCIN system. Comput Biomed Res (1975) 1.59

A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404. Int J Radiat Oncol Biol Phys (1999) 1.58

Solar neutrinos: a scientific puzzle. Science (1976) 1.56

What scientists funded by the tobacco industry believe about the hazards of cigarette smoking. Am J Public Health (1991) 1.56

The association between greater continuity of care and timely measles-mumps-rubella vaccination. Am J Public Health (2000) 1.49

Cyclists should wear helmets. BMJ (1997) 1.49

Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man. Circulation (1979) 1.47

Minor head injury in children: current management practices of pediatricians, emergency physicians, and family physicians. Arch Pediatr Adolesc Med (1998) 1.47

Tissue-specific expression of a type I adenylyl cyclase rescues the rutabaga mutant memory defect: in search of the engram. Learn Mem (2000) 1.46

High-risk myocardial infarction patients appear to derive more mortality benefit from short door-to-balloon time than low-risk patients. Int J Clin Pract (2009) 1.45

Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi: comparison of methods. J Clin Microbiol (1997) 1.45

Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy. Clin Pharmacol Ther (1986) 1.44

Patient satisfaction with realtime teledermatology in Northern Ireland. J Telemed Telecare (1998) 1.43

MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol (1999) 1.42

Diagnostic yield of duodenal biopsy and aspirate in AIDS-associated diarrhea. Am J Gastroenterol (1996) 1.40

Screening--sensitivity, specificity and hepatitis C. Med J Aust (1996) 1.38

Design considerations for AIDS trials. N Engl J Med (1990) 1.38

The relation between hospital experience and in-hospital mortality for patients with AIDS-related PCP. JAMA (1989) 1.36

In vivo transcription of R-plasmid deoxyribonucleic acid in Escherichia coli strains with altered antibiotic resistance levels and/or conjugal proficiency. J Bacteriol (1976) 1.34

Structure of the Tie2 RTK domain: self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail. Structure (2000) 1.32

Isolation of a microsporidian from a human patient. J Infect Dis (1990) 1.27

Quantitation of the RNA polymerase II transcription machinery in yeast. J Biol Chem (2001) 1.27

Diabetes mellitus after renal transplantation in the cyclosporine era--an analysis of risk factors. Transplantation (1991) 1.24

Aligned microcontact printing of micrometer-scale poly-L-lysine structures for controlled growth of cultured neurons on planar microelectrode arrays. IEEE Trans Biomed Eng (2000) 1.24

cAMP-dependent protein kinase-mediated phosphorylation of cystic fibrosis transmembrane conductance regulator residue Ser-753 and its role in channel activation. J Biol Chem (1995) 1.22

Diagnostic accuracy and clinical management by realtime teledermatology. Results from the Northern Ireland arms of the UK Multicentre Teledermatology Trial. J Telemed Telecare (1998) 1.22

Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy. J Virol (1999) 1.20

Carcinogenicity, metabolism and Ki-ras proto-oncogene activation by 7,12-dimethylbenz[a]anthracene in rainbow trout embryos. Carcinogenesis (1993) 1.20

Refinement of the bis-(thioacetoxy) aurate (I) method for the electron microscopic localization of acetylcholinesterase and nonspecific cholinesterase. J Histochem Cytochem (1974) 1.17

Fryns syndrome phenotype caused by chromosome microdeletions at 15q26.2 and 8p23.1. J Med Genet (2005) 1.16

High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers. J Urol (2000) 1.16

Double pathology in Rasmussen's syndrome: a window on the etiology? Neurology (1998) 1.14

Developmental regulation of annexin II (Lipocortin 2) in human brain and expression in high grade glioma. Cancer Res (1992) 1.13

Electron microscope localization of acetylcholinesterase and butyrylcholinesterase in the superior cervical ganglion of the cat. I. Normal ganglion. J Cell Biol (1978) 1.13

Radiation doses delivered to the skin, bone marrow and gonads of patients during cardiac catheterisation and angiocardiography. Br J Radiol (1968) 1.13

Electron microscope localization of acetylcholinesterase and butyrylcholinesterase in the superior cervical ganglion of the cat. II. Preganglionically denervated ganglion. J Cell Biol (1981) 1.12

Structural gene coding for multifunctional protein carrying orotate phosphoribosyltransferase and OMP decarboxylase activity is located on long arm of human chromosome 3. Somatic Cell Genet (1983) 1.12

Participation of the school community in AIDS education: an evaluation of a high school programme in South Africa. AIDS Care (1994) 1.12

Observation and treatment of neonatal narcotic withdrawal. Am J Obstet Gynecol (1977) 1.11

Synaptic potentials, after-potentials, and slow rhythms of lateral geniculate neurones. J Physiol (1960) 1.11

Diffraction-based cell detection using a microcontact printed antibody grating. Anal Chem (1998) 1.11

Biotechnology of lactic acid bacteria with special reference to bacteriophage resistance. Antonie Van Leeuwenhoek (1996) 1.11

Effects of stable flies (Diptera: Muscidae) on weight gains of grazing yearling cattle. J Econ Entomol (2001) 1.10

Experimental reproduction of viral chorioretinitis in kangaroos. Aust Vet J (1999) 1.10

Organo-axial volvulus of the stomach with eventration of the diaphragm. S Afr Med J (1973) 1.09

Effects of aldehyde fixation and of preganglionic denervation on acetylcholinesterase and butyrocholinesterase of cat autonomic ganglia. J Histochem Cytochem (1974) 1.09

Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr (1999) 1.09

Black suicide in the seventies: current trends. Suicide Life Threat Behav (1979) 1.08

Studies of methylmalonyl coenzyme A carbonylmutase activity in methylmalonic acidemia. I. Correlation of clinical, hepatic, and fibroblast data. Pediatr Res (1975) 1.08

The fate of free male condoms distributed to the public in South Africa. AIDS (2001) 1.07

A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS. J Infect Dis (1993) 1.07

The detection and significance of calcifications in the breast: a radiological and pathological study. Br J Radiol (1976) 1.07

Thromboprophylaxis following caesarean section; hospital protocols are necessary. N Z Med J (2001) 1.06

Isla Vista virus: a genetically novel hantavirus of the California vole Microtus californicus. J Gen Virol (1995) 1.06

Fetal stress from methadone withdrawal. Am J Obstet Gynecol (1975) 1.05

Identification of two additional exons at the 3' end of the amelogenin gene. Arch Oral Biol (1998) 1.04

Evaluating the performance of a computer-based consultant. Comput Programs Biomed (1979) 1.04

Measles in the tropics and public health practice. Trans R Soc Trop Med Hyg (1982) 1.04

Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1beta- induced cytotoxicity and reduces nitric oxide production. J Clin Invest (1998) 1.04

Persistently negative HIV-1 antibody enzyme immunoassay screening results for patients with HIV-1 infection and AIDS: serologic, clinical, and virologic results. Seronegative AIDS Clinical Study Group. AIDS (1999) 1.03

Surgery of left paraduodenal hernia. Am J Surg (1975) 1.03

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity. Am Heart J (1979) 1.03

Patient cost-benefit analysis of teledermatology measured in a randomized control trial. J Telemed Telecare (1999) 1.03